
News
-
Newest uMotif product release delivers next-gen eCOA/ePRO
Read More -
Steve Rosenberg joins Craig Lipset, Co-Chair DTRA to discuss his passion for patient engagement
Read More -
uMotif – first new validated eCOA/ePRO innovation since paper instruments deployed on smartphones
Read More -
uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now
Read More -
uMotif expands leadership team to support growth in US and EU markets
Read More -
uMotif and ClinOne unify eCOA / ePRO and eConsent
Read More -
$25.5m of new investment from Athyrium Capital Management fund
Read More -
Achieving more meaningful patient engagement in rare disease trials
Read More -
AbbVie and uMotif support rheumatoid arthritis patients with BYOD approach
Read More